Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic steatohepatitis (NASH) – current treatment recommendations and future developments
Elke Roeb, Andreas Geier
Zeitschrift für Gastroenterologie (2019) Vol. 57, Iss. 04, pp. 508-517
Closed Access | Times Cited: 85

Showing 26-50 of 85 citing articles:

SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies
Wen Wang, Xiaojing Liu, Peiyao Wei, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 16
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01, pp. e67-e161
Open Access | Times Cited: 3
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 02, pp. e213-e282
Open Access | Times Cited: 3
Non-alcoholic fatty liver diseases: current challenges and future directions
Elke Roeb
Annals of Translational Medicine (2021) Vol. 9, Iss. 8, pp. 726-726
Open Access | Times Cited: 21
Persistent Lipid Accumulation Leads to Persistent Exacerbation of Endoplasmic Reticulum Stress and Inflammation in Progressive NASH via the IRE1α/TRAF2 Complex
Na Lei, Hongfei Song, Ling Zeng, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3185-3185
Open Access | Times Cited: 8
Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update
Tsipora M. Huisman, Douglas T. Dieterich, Scott L. Friedman
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 329-338
Open Access | Times Cited: 18
Complement System in Alcohol-Associated Liver Disease
Lazara Elena Santiesteban-Lores, Milena Carvalho Carneiro, Lourdes Isaac, et al.
Immunology Letters (2021) Vol. 236, pp. 37-50
Open Access | Times Cited: 18
Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review
Elke Roeb
Visceral Medicine (2021) Vol. 38, Iss. 2, pp. 126-132
Open Access | Times Cited: 18
Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
Inês C. M. Simões, Justyna Janikiewicz, Judith Bauer, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 2871-2871
Open Access | Times Cited: 22
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care
Wolf Peter Hofmann, Peter Buggisch, Lisa Schubert, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100168-100168
Open Access | Times Cited: 19
Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
Eleftheria Galatou, Elena A. Mourelatou, Sophia Hatziantoniou, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1060-1060
Open Access | Times Cited: 11
Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis
Ting Wang, Dehua Wang, Ge Kuang, et al.
Free Radical Biology and Medicine (2024) Vol. 217, pp. 29-47
Closed Access | Times Cited: 2
Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis
Suye Ran, Lingyu Song, Hong Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301133-e0301133
Open Access | Times Cited: 2
Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice
Karuna Irungbam, M Roderfeld, Hannah Glimm, et al.
Laboratory Investigation (2020) Vol. 100, Iss. 11, pp. 1411-1424
Open Access | Times Cited: 16
Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
Valentin Metzner, G. Herzog, Tobias Heckel, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 753-753
Open Access | Times Cited: 9
Challenges and opportunities in drug development for nonalcoholic steatohepatitis
Matthias Ocker
European Journal of Pharmacology (2020) Vol. 870, pp. 172913-172913
Closed Access | Times Cited: 13
Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people
Cuiping Shao, Qiushi Cheng, Shuhui Zhang, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 2, pp. 655-662
Open Access | Times Cited: 8
Serum mitochondrial bioenergetics as fingerprint of the hepatic one: how to monitor genetic MASLD
Erika Paolini, Miriam Longo, Marica Meroni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development
Farah Khaznadar, Omar Khaznadar, Ana G. Petrovic, et al.
(2024)
Open Access | Times Cited: 1
Pueraria lobata radix (Ge Gen)-containing traditional Chinese medicine prescriptions for the treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis
H C Wang, Huilin Liu, Xiangmin Deng, et al.
European Journal of Integrative Medicine (2024), pp. 102405-102405
Closed Access | Times Cited: 1
Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier
Yan Shu, H U Li Lin, Yu Jin, et al.
Life Sciences (2024), pp. 123095-123095
Closed Access | Times Cited: 1
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
Sabrina Voesch, Michael Bitzer, Albert Jörg, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01, pp. e56-e130
Open Access | Times Cited: 7
Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis
Caicai Zhang, Baoyong Zhang, Aifang Chen, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 46, Iss. 4, pp. 101833-101833
Closed Access | Times Cited: 9
Effect of Jiangan‐Jiangzhi Pill on Gut Microbiota and Chronic Inflammatory Response in Rats with Non‐Alcoholic Fatty Liver
Zeyu Zhao, Jing Wang, Wei Ren, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 5
Closed Access | Times Cited: 6
Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity
Diego Meneses, Antonio Olveira, Ramón Corripio, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2022) Vol. 69, Iss. 3, pp. 178-188
Closed Access | Times Cited: 5

Scroll to top